HALCION cpr 0.25 mg 30 pce
7680413141762
CH-41314
N05CD05
01.03.1.
1 / 2
google
Details
- Product number
- 4131401
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- triazolamum 0.25 mg, lactosum monohydricum 72 mg, cellulosum microcristallinum, silica colloidalis anhydrica, maydis amylum, magnesii stearas, natrii docusas, E 211 0.15 mg, E 132, pro compresso corresp. natrium 0.068 mg.
Articles (1)
Halcion 0.25 mg, Tabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.25 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
72.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.15 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
0.068 MG | Substance | HBESI |
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 41314
- Drug name
- Halcion, Tabletten
- Galenic form
- TAB
- ATC Code
- N05CD05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 25/04/1978
- Authorization expiration date
- 30/09/2025
- IT number
- 01.03.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- HALCION cpr 0.25 mg 30 pce
- Description (DE)
- HALCION Tabl 0.25 mg 30 Stk
- Market launch
- 25/04/1978
- Market withdrawal
- 30/09/2025
- Narcotic (BTM)
- B